个人简介
In 2000, Dr.LOU Fang graduated from Nanjing Medical University with a master's degree. Since then, She has worked at SRRSH and engaged in medical oncology, teaching, research and other related work. She also went to Loma Linda University School of Medicine and the National Cancer Center of Hope City in the United States. Her research field is early diagnosis and prevention of various tumors, comprehensive treatment of various solid tumors such as chemotherapy, targeted therapy, immunotherapy and clinical research of new drugs. She has published several relevant papers in domestic and international journals, and led and participated in several national projects. She has also participated in a number of global large-scale multi-center clinical studies on new anti-tumor drugs and won the Advanced Worker of the hospital for many times.
学术任职
Member of the Malignant Melanoma Special Committee of the Chinese Society of Clinical Oncology
Member of the Liver Cancer Professional Committee of the Chinese Society of Clinical Oncology
Member of the Sarcoma Professional Committee of the Chinese Anti-Cancer Association
Member of the National Health Commission Capacity Building and Continuing Education Oncology Expert Committee
相关专家
-
WANG Xian Medical OncologyProfessor/Senior ConsultantPrevention, diagnosis and differential diagnosis of various malignant tumors as well as the chemotherapy and molecular targeted drug therapy of malignant tumors;preoperative neoadjuvant therapy of breast cancer, postoperative adjuvant therapy and comprehensive treatment of advanced breast cancer; clinical trials of novel antitumor drugs.
-
PAN Hongming Medical OncologySenior Consultant, professorDiagnosis, chemotherapy, targeting, immunization and radiofrequency ablation of various malignant tumors, and clinical trials of anti-tumor drugs.
-
FANG Yong Medical OncologySenior ConsultantMinimally invasive ablation of lung tumor; tumor biological immunotherapy; comprehensive treatment.
-
LI Da Medical OncologySenior ConsultantComprehensive treatment of lung cancer and digestive tract tumors, minimally invasive treatment of solid tumors and the treatment of drug toxicity and side effects, and drug resistance mechanism and delivery in vivo.
-
LOU Haizhou Medical OncologySenior ConsultantDiagnosis of various solid tumors, chemotherapy, targeted therapy, immunotherapy and integrated treatment of traditional Chinese and Western medicine, especially the comprehensive treatment of lung cancer and digestive tract tumors.
-
ZHENG Yu Medical OncologySenior ConsultantChemotherapy, targeted therapy and immunotherapy of lung cancer, digestive tract tumor and cancers of unknown primary; radiofrequency ablation of primary or metastatic tumor of liver; management of side effects of chemotherapy and supportive treatment; precise individualized treatment of gastric cancer and comprehensive treatment of liver and lung metastasis of colorectal cancer.
-
PAN Qin Medical OncologyConsultantStandardized diagnosis and treatment of tumor nutrition; diagnosis and treatment of malignant lymphoma; palliative care.
-
JIN Wei Medical OncologyConsultantA variety of common tumor diagnosis, chemotherapy, targeted therapy, immunotherapy and other individualized comprehensive treatment and minimally invasive radiofrequency therapy.
-
HU Hong Medical OncologyConsultantComprehensive diagnosis and treatment of common malignant tumors, tumor immunity and targeted therapy, tumor radiofrequency ablation, clinical research of new tumor drugs.
-
SHOU Jiawei Medical OncologyConsultantImmune and targeted therapy and drug resistance strategies for lung cancer; Tumor genetics and vaccines; Liver and gallbladder tumors; Tumor ablation techniques.
-
LU Haiqi Medical OncologyConsultantComprehensive treatment of common malignant tumors, with particular expertise in the diagnosis and precision treatment of breast, digestive system, and urinary system malignant tumors, as well as multiple primary tumors. She also specializes in research on drug resistance mechanisms and genetic screening for high-risk tumor populations.
-
ZHOU Xiaoyun Medical OncologyDeputy Chief PhysicianDiagnosis and treatment of ovarian cancer, lung cancer, gastric cancer, colon-rectal cancer, liver cancer, pancreatic cancer, breast cancer, especially the accurate treatment of ovary cancer, lung cancer and gastrointestinal tumors.
-
YOU Liangkun Medical OncologyConsultantTargeted therapy, immunotherapy, and chemotherapy for various solid tumors; comprehensive treatment for lung cancer; clinical research on lung cancer, pancreatic cancer, urinary system tumors, and nutritional therapy for tumors.
-
SHENG Jin Medical OncologyConsultantMolecular targeted therapy, chemotherapy, and immunotherapy for lung cancer, gastric cancer, colon cancer, pancreatic cancer, and malignant tumors with unknown primary focus; comprehensive treatment of solid tumors and case management, palliative care; molecular gene analysis and precision treatment of lung cancer and digestive tract tumors.
-
GONG Liu Medical OncologyConsultantLung cancer, neuroendocrine neoplasm, gastric cancer, colorectal cancer, hepatocarcinoma, pancreatic cancer, carcinoma of the bile duct and gynecological malignancies, especially the accurate treatment of NSCLC, SCLC and neuroendocrine neoplasm.
-
YAO Junlin Medical OncologyConsultantIntegrated management of malignant gastrointestinal tumors and breast cancer, including chemotherapy, targeted therapy, and immunotherapy for gastric cancer, colorectal cancer, liver cancer, cholangiocarcinoma, pancreatic cancer, esophageal cancer, and breast cancer; clinical research on novel drugs for advanced solid tumors.
-
ZHAI Chongya Medical OncologyConsultantComprehensive diagnosis and treatment of various solid tumors such as digestive tract malignant tumors and lung malignant tumors, as well as handling of adverse reactions to drugs.
-
WU Zhuoxuan Medical OncologyConsultantPrecision treatment of lung cancer and gastrointestinal tract tumors; holistic management of brain metastases; clinical trials of new drugs for solid tumors.
-
LI Hongsen Medical OncologyConsultantIndividualized treatment of malignant tumors of the respiratory and digestive tracts. Clinical research of new anti-tumor drugs.